@birdm4n78.bsky.social
Reposted
More than anything, the major difference I'm seeing between this place and Threads is how successful engagement bait is. A thread with 30 likes and 3,000 comments gets a TON of traction, giving incentive to post hurtful garbage just to get a reaction.
Getting off Meta is sounding better and better.
Getting off Meta is sounding better and better.
January 12, 2025 at 4:38 AM
More than anything, the major difference I'm seeing between this place and Threads is how successful engagement bait is. A thread with 30 likes and 3,000 comments gets a TON of traction, giving incentive to post hurtful garbage just to get a reaction.
Getting off Meta is sounding better and better.
Getting off Meta is sounding better and better.
Reposted
Woke up to 150,000 followers, which is a heck of a way to say "good morning." Thank you, folks, for giving me a follow and for being part of Bluesky. If you're new, I hope you like it here. To celebrate 150K, I've made a donation to World Central Kitchen, which is feeding those in need.
wck.org
wck.org
World Central Kitchen
Founded in 2010 by Chef José Andrés, World Central Kitchen (WCK) is a nonprofit organization that is first to the frontlines providing fresh meals in response to crises. Applying our model of quick ac...
wck.org
November 17, 2024 at 2:08 PM
Woke up to 150,000 followers, which is a heck of a way to say "good morning." Thank you, folks, for giving me a follow and for being part of Bluesky. If you're new, I hope you like it here. To celebrate 150K, I've made a donation to World Central Kitchen, which is feeding those in need.
wck.org
wck.org
Reposted
Reposted
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
medicine.washu.edu
November 16, 2024 at 3:09 PM
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free